Ribbon 1: Randomized, double-blind, placebo-controlled, phase III-trial of chemotherapy with or without bevacizumab for first-line treatment of Her2-negative locally recurrent or metastatic breast cancer. - Robert,N.J.; Dieras,V.; Glaspy,J. (J Clin Oncol, 2009)